0.50-0.54) was statistically significantly stronger than with outpatient systolic BP (r=0.25, 95% confidence Background. Left ventricular hypertrophy (LVH ) is both common and an important predictor of risk of interval 0.23-0.27). The same was true for the correlation between LVMI and mean 24-h ambulatory diadeath in end-stage renal failure ( ESRF ). In mild to moderate chronic renal failure (CRF ), the timing of stolic BP (r=0.42, 95% confidence interval 0.40-0.44), and outpatient diastolic BP (r=0.22, 95% confidence onset of LVH and the factors involved in its initial development have not been fully elucidated. The pre-interval 0.20-0.24).
in the previous 3 months were excluded. Clinic BP, Introduction 24-h ambulatory BP, echocardiography, body mass index (BMI ), serum creatinine (SCr), creatinine clearCardiovascular disease is the leading cause of death in ance (CrCl ), haemoglobin ( Hb), fasting cholesterol patients on renal replacement therapy [1] [2] [3] . Left vent-(CHOL), triglyceride TRlGL), plasma glucose, calcium ricular hypertrophy (LVH ) is a strong predictor of (Ca), phosphate ( PO 4 ), alkaline phosphatase (ALK myocardial infarction, cardiac failure, sudden death, PHOS ), parathyroid hormone (PTH ) concentrations, and stroke in patients with essential hypertension and and 24-h urinary protein were assessed in all patients.
normal renal function and those with end-stage renal Seventy-seven per cent were on antihypertensive disease ( ESRD) [4] [5] [6] [7] . LVH is common in ESRD and medication.
frequently predates the initiation of dialysis treatment Results. LVH was detected in 16% of patients with [7] [8] [9] , suggesting that the factors responsible may be CrCL >30 ml/min, and 38% of patients with CrCl present in early renal impairment. Information regard-<30 ml/min. By stepwise regression analysis, ambulating the stage of renal impairment at which LVH occurs, ory systolic BP (P<0.0001), male gender (P<0.0001), the important factors involved in its initial develop-BMI (P<0.0002), and Hb concentration (P<0.002) ment, and optimum monitoring and management are were the only independent determinants of left ventriscant. cular (LV ) mass. Nocturnal systolic BP (P<0.02) was A number of factors potentially affecting cardiovasthe main determinant of LVH in the group of patients cular outcome have been postulated or defined in with advanced CRF. The correlation between left patients with ESRD [3, [7] [8] [9] [10] [11] [12] [13] [14] , but these have not been ventricular mass index (LVMI ) and mean 24-h ambuassessed thoroughly in moderate renal impairment. latory systolic BP (r=0.52, 95% confidence interval
The 24-h ambulatory BP profile in patients with CRF, those on haemodialysis, and renal transplant recipients Methods between 0700 and 2200 hours (daytime), and hourly between 2200 and 0700 hours (night-time). The mean 24-h daytime and night-time BP for both systolic (sBP) and diastolic (dBP) From a cohort of 120 non-diabetic patients who had been BP, and BP dipping, were calculated. Calculations were also attending a nephrology clinic, 118 agreed to participate in made of values during 'awake' and 'sleep' periods. As there the study. Of these, we selected for analysis 85 subjects, 37
were no significant differences between these values and mean male and 48 female, mean age 49 (SD 14) years, mean CrCI daytime and night-time BP values, the latter were used for 39 (SD 30) mlNmin. We excluded from analysis patients with analysis. Dipping was defined as a reduction in night-time known cerebrovascular, peripheral vascular, cardiac valvmean arterial pressure greater than 10% of the daytime mean ular, or coronary disease, those with a previous hitory of arterial pressure [17] . Duration of hypertension was greater poor compliance with antihypertensive drug treatment and in group 2 ( Table 1 ). Clinic and ambulatory systolic BP those in whom such treatment had been altered during the levels were significantly higher in group 2. There was no preceding 3 months. All patients studied were clinically and significant difference in the levels of clinic or ambulatory biochemically stable. Seventy-seven per cent of patients were diastolic BP between the groups. receiving antihypertensive treatment. Fourteen per cent were Two-dimensionally guided M-mode echocardiography Afro-Caribbean, and 13% were smokers. Fifteen patients (Acuson) was performed by one experienced observer ( MG), had polycystic kidney disease and seven had reflux nephrounaware of other results, according to the recommendations pathy. Remaining patients had biopsy-proven glomeruloof the American Society of Echocardiography ( ASE) [18] . nephritis (15 ), interstitial nephritis (13 ), focal segmental Interventricular septum thickness ( IVS), posterior left ventriglomerulosclerosis ( 6), vasculitis (7), hypertensive nephrocular wall thickness (PLVW ), end-diastolic (LVEDD), and pathy ( 4), and other diagnoses (3 ). In 15 patients the renal end-systolic (LVESD) left ventricular internal dimensions diagnosis was unknown. The population was divided into were measured. LV dilatation was defined as LVEDD two groups according to the CrCl level: group 1: >30 ml/min >5.6 cm. Left ventricular mass ( LVM) was determined by (n=43 ), and group 2: <30 ml/min (n=42 Ca, PO 4 , ALK PHOS, and PTH (IRMA 2-site chemilumines-−LVEDD3]+0.6 g cence assay for intact PTH (Ciba-Corning)) levels were measured on the day of the study and the results were Left ventricular mass index ( LVMI ) was calculated by dividing LVM by body surface area. To determine the prevalence compared with computer-stored previous laboratory data.
Groups 1 and 2 patients were similar in age and BMI. of LVH, sex-specific criteria were used [ 20]: (men LVMI>131 g/m2; women LVMI>100 g/m2). Relative wall thickness Levels of CHOL, TRIGL, ALK PHOS, and Ca were also similar in the two groups. Degree of proteinuria, PO 4 , and (RWT ), a measure of left ventricular geometry, was found between Hb and LVMI (r=−0.44, P<0.004).
Other significant associations of LVMI were U Prot
Results output (r=0.25, P<0.03), PTH (r= 0.23, P<0.004), and age (r=0.21, P<0.05). No significant association was found between LVMI and underlying renal disease, Hypertension (mean 24-h sBP>140, mean 24-h dBP>90 mmHg) despite treatment, was present in serum Ca, PO 4 and serum CaPO 4 product, ALK PHOS, CHOL, or TRIGL levels. A significant correla-11 patients in group 1 (26%) and 17 patients in group 2 (46%). In the majority, the degree of hyperten-tion was found between LVM and BMI (r=0.40, P<0.002). A significant association was found between sion was mild, i.e. sBP<160 mmHg, dBP<100 mmHg. In group 1, 26% of patients were normotensive, 30% BMI and sBP dip (r=−0.37, P<0.02). were on one antihypertensive agent, 35% were on two or more agents, and 9% were untreated hypertensives. Independent determinants of LV mass In group 2, 7% of patients were normotensive, 28%
By stepwise multiple regression analyses, male gender, were on one antihypertensive agent, 60% were on two BMI, ambulatory sBP, and Hb concentration were the or more agents, and five were untreated hypertensives.
only independent determinants of LVM and together Forty per cent (17/43) of group 1 and 52% (22/42) explained 58% of the variability in the whole populaof group 2 patients were categorized as non-dippers.
tion. Daytime sBP was the main BP determinant of The loss in physiological night-time BP was observed LVM in patients in group 1. Night-time sBP was the in hypertensive patients, regardless of whether BP was most important determinant of LVM in group 2. poorly or well controlled, but not in normotensive (Table 2 ). subjects. There was no association between non-dipper status and number or type of antihypertensive agents.
The prevalence of LVH was 16% in group 1 and Discussion 38% in group 2. Half the patients with advanced renal failure (CrCl<10 ml/min) had LVH. The percentage of concentric LVH was 7 and 26% in groups 1 and 2 None of our patients had clinical evidence of cardiac disease, and our results confirm the importance of respectively. LV dilatation also increased with progression of renal failure from 9% in group 1 to 17% in echocardiography in making an early diagnosis of LVH. We found that LVH, which identifies patients at group 2. Systolic function was preserved in all but one patient in group 2.
risk of cardiac death and stroke [4, 7] , increases with progression of renal failure and is particularly common A highly significant positive correlation was found between LVMI and mean ambulatory systolic (r=0.52, in patients with advanced CRF. The incidence of LV dilatation, also a marker of poor prognosis in uraemic P<0.001) and diastolic (r=0.42, P<0.0001) pressures ( Figure 1 ). Correlations with mean clinic systolic (r= patients [21 ] , increases with the degree of renal impairment. Systolic dysfunction appears to be a late event 0.25, P <0.03) and diastolic (r=0.22, P<0.05) pressures were significant but less strong. There was a in renal failure.
Our results confirm the superiority of 24-h ambulatsignificant difference between the correlation coefficients for the relationship between LVMI and mean ory BP monitoring in establishing or refuting the advanced CRF. This may account for the fact that such factors have previously been postulated as determinants of LVH in dialysis patients [9, 24] . Although the prevalence of LVH increases with progression of presence of significant hypertension (despite treatment) renal failure, we did not demonstrate that SCr concenwhen compared with casual single outpatient clinic tration per se is an independent contributor to alterarecordings. In our cohort of patients, ambulatory BP tion in cardiac anatomy. correlated more closely with LVH than clinic BP, as
The factors we describe do not account in full for has been widely reported in non-renal hypertensive all the variability in LV mass observed. Whether previsubjects [5, 16, 21] .
ous hypertension, no longer present at the time of our We also confirm that absence of nocturnal decline study, accounts for this discrepancy or whether other in blood pressure is common in moderate to severe renal impairment [15 ] . It has recently been shown that factors, unidentified to date, are relevant is unknown.
